NCT06328465View on ClinicalTrials.gov

fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases

NARecruitingINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

November 22, 2019

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Invasive Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
Interventions
DIAGNOSTIC_TEST

Diffusion whole body MRI

Diffusion whole body MRI protocol, consisting of sagittal T1-weighted and T2-weighted sequences on the whole spine, axial T1 weighted, T2-weighted and diffusion-weighted images from head to mid-thigh, performed on a 1.5 T scanner.

Trial Locations (1)

20141

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER